Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeBlueWind Medical

BlueWind Medical

Positive Long-Term Results of the BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

8/30/18: The prospective study was conducted in four leading clinical centers in the UK and the Netherlands that evaluated the long-term performance and safety of the RENOVA iStim™ for the management of OverActive Bladder (OAB), including Urinary Urge Incontinence (UUI) and symptoms of Urgency Frequency (UF).

BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim™ Implantable Tibial Nerve Neuromodulator for Overactive Bladder

6/14/18: RENOVA iStim™ is an innovative, battery-less, leadless, miniature, implantable Tibial Nerve Neuromodulation System, for the management of overactive bladder.

By using this website you agree to accept Medical Device News Magazine Privacy Policy